Quarterly report · Q3
2385.TEDINET S100TEAA
Period2023-07-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.8bn | 2023-07-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥8.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.6bn | 2022-07-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | −¥560m | 2023-07-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥785m | 2022-07-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | −¥529m | 2023-07-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥727m | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥785m | 2022-07-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥529m | 2023-07-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥784m | 2022-07-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥575m | 2023-07-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥452m | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥496m | 2022-07-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥575m | 2023-07-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥500m | 2022-07-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥7.0bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥8.2bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥8.7bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥641m | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.1bn | at 2023-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.3bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.2bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥7.2bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.9bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.9bn | at 2023-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥-21.96 | 2023-07-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.31 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.27 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.97 | 2022-07-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.97 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 90.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 49
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2024-03-31 | −¥17m |
| Reconciling Itemsreconciling | revenue external | 2023-07-01 → 2024-03-31 | ¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2024-03-31 | −¥19m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2024-03-31 | −¥225m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2023-07-01 → 2024-03-31 | ¥192m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2023-07-01 → 2024-03-31 | ¥192m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2023-07-01 → 2024-03-31 | −¥51m |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2023-07-01 → 2024-03-31 | ¥982m |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2023-07-01 → 2024-03-31 | ¥982m |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2023-07-01 → 2024-03-31 | −¥177m |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue | 2023-07-01 → 2024-03-31 | ¥1.9bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue external | 2023-07-01 → 2024-03-31 | ¥1.9bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue intersegment | 2023-07-01 → 2024-03-31 | ¥6m |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | segment profit | 2023-07-01 → 2024-03-31 | −¥184m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue | 2023-07-01 → 2024-03-31 | ¥255m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue external | 2023-07-01 → 2024-03-31 | ¥242m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue intersegment | 2023-07-01 → 2024-03-31 | ¥13m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | segment profit | 2023-07-01 → 2024-03-31 | −¥686,000 |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue | 2023-07-01 → 2024-03-31 | ¥490m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue external | 2023-07-01 → 2024-03-31 | ¥490m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | segment profit | 2023-07-01 → 2024-03-31 | ¥78m |
| —segment total | revenue | 2023-07-01 → 2024-03-31 | ¥3.9bn |
| —segment total | revenue external | 2023-07-01 → 2024-03-31 | ¥3.8bn |
| —segment total | revenue intersegment | 2023-07-01 → 2024-03-31 | ¥19m |
| —segment total | segment profit | 2023-07-01 → 2024-03-31 | −¥336m |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-03-31 | −¥1m |
| Reconciling Itemsreconciling | revenue external | 2022-07-01 → 2023-03-31 | ¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-03-31 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-03-31 | −¥226m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥404m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥404m |
| jpcrp040300-q3r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥68m |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥3.4bn |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥3.4bn |
| jpcrp040300-q3r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥701m |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥1.9bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥1.9bn |
| jpcrp040300-q3r_E05367-000Functional Food Retailingreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥115m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥382m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥380m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥3m |
| jpcrp040300-q3r_E05367-000Functional Material Developmentreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥43m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥463m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥463m |
| jpcrp040300-q3r_E05367-000Health Care Support Servicereportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥83m |
| —segment total | revenue | 2022-07-01 → 2023-03-31 | ¥6.6bn |
| —segment total | revenue external | 2022-07-01 → 2023-03-31 | ¥6.6bn |
| —segment total | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥3m |
| —segment total | segment profit | 2022-07-01 → 2023-03-31 | ¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 314
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 414621000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 317340000 | JPY |
| Merchandise | Prior1YearInstant | 815853000 | JPY |
| Merchandise | CurrentQuarterInstant | 540725000 | JPY |
| Work in process | Prior1YearInstant | 161009000 | JPY |
| Work in process | CurrentQuarterInstant | 166261000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 319243000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 440629000 | JPY |
| Other ca | Prior1YearInstant | 312650000 | JPY |
| Other ca | CurrentQuarterInstant | 334131000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -35000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -4000 | JPY |
| Current assets | Prior1YearInstant | 7969196000 | JPY |
| Current assets | CurrentQuarterInstant | 6736501000 | JPY |
| Property plant and equipment | Prior1YearInstant | 52041000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 51670000 | JPY |
| Other ia | Prior1YearInstant | 46586000 | JPY |
| Other ia | CurrentQuarterInstant | 40926000 | JPY |
| Intangible assets | Prior1YearInstant | 46586000 | JPY |
| Intangible assets | CurrentQuarterInstant | 40926000 | JPY |
| Investment securities | Prior1YearInstant | 20738000 | JPY |
| Investment securities | CurrentQuarterInstant | 20738000 | JPY |
| Other ioa | Prior1YearInstant | 151419000 | JPY |
| Other ioa | CurrentQuarterInstant | 127715000 | JPY |
| Investments and other assets | Prior1YearInstant | 172157000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 148453000 | JPY |
| Noncurrent assets | Prior1YearInstant | 270785000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 241050000 | JPY |
| Assets | Prior1YearInstant | 8239982000 | JPY |
| Assets | CurrentQuarterInstant | 6977552000 | JPY |
| Accounts payable trade | Prior1YearInstant | 407707000 | JPY |
| Accounts payable trade | CurrentQuarterInstant | 130714000 | JPY |
| Income taxes payable | Prior1YearInstant | 43869000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 2056000 | JPY |
| Contract liabilities | Prior1YearInstant | 307374000 | JPY |
| Contract liabilities | CurrentQuarterInstant | 285692000 | JPY |
| Provision for loss on order received cl | Prior1YearInstant | 27207000 | JPY |
| Provision for loss on order received cl | CurrentQuarterInstant | 13590000 | JPY |
| Other cl | Prior1YearInstant | 262880000 | JPY |
| Other cl | CurrentQuarterInstant | 190682000 | JPY |
| Current liabilities | Prior1YearInstant | 1049039000 | JPY |
| Current liabilities | CurrentQuarterInstant | 622736000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 18725000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 17424000 | JPY |
| Other ncl | Prior1YearInstant | － | JPY |
| Other ncl | CurrentQuarterInstant | 368000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 18725000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 17792000 | JPY |
| Liabilities | Prior1YearInstant | 1067764000 | JPY |
| Liabilities | CurrentQuarterInstant | 640529000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |